- Nipah virus infection in humans causes a range of clinical presentations, from asymptomatic infection (subclinical) to acute respiratory infection and fatal encephalitis.
- The case fatality rate is estimated at 40% to 75%. This rate can vary by outbreak depending on local capabilities for epidemiological surveillance and clinical management.
- Nipah virus can be transmitted to humans from animals (such as bats or pigs), or contaminated foods and can also be transmitted directly from human-to-human.
- Fruit bats of the Pteropodidae family are the natural host of Nipah virus.
- There is no treatment or vaccine available for either people or animals. The primary treatment for humans is supportive care.
- The 2018 annual review of the WHO R&D Blueprint list of priority diseases indicates that there is an urgent need for accelerated research and development for the Nipah virus.
Nipah virus (NiV) is a zoonotic virus (it is transmitted from animals to humans) and can also be transmitted through contaminated food or directly between people. In infected people, it causes a range of illnesses from asymptomatic (subclinical) infection to acute respiratory illness and fatal encephalitis. The virus can also cause severe disease in animals such as pigs, resulting in significant economic losses for farmers.
Although Nipah virus has caused only a few known outbreaks in Asia, it infects a wide range of animals and causes severe disease and death in people, making it a public health concern.
Nipah virus was first recognized in 1999 during an outbreak among pig farmers in, Malaysia. No new outbreaks have been reported in Malaysia since 1999.
It was also recognized in Bangladesh in 2001, and nearly annual outbreaks have occurred in that country since. The disease has also been identified periodically in eastern India.
Other regions may be at risk for infection, as evidence of the virus has been found in the known natural reservoir (Pteropus bat species) and several other bat species in a number of countries, including Cambodia, Ghana, Indonesia, Madagascar, the Philippines, and Thailand.
During the first recognized outbreak in Malaysia, which also affected Singapore, most human infections resulted from direct contact with sick pigs or their contaminated tissues. Transmission is thought to have occurred via unprotected exposure to secretions from the pigs, or unprotected contact with the tissue of a sick animal.
In subsequent outbreaks in Bangladesh and India, consumption of fruits or fruit products (such as raw date palm juice) contaminated with urine or saliva from infected fruit bats was the most likely source of infection.
There are currently no studies on viral persistence in bodily fluids or the environment including fruits.
Human-to-human transmission of Nipah virus has also been reported among family and care givers of infected patients.
During the later outbreaks in Bangladesh and India, Nipah virus spread directly from human-to-human through close contact with people’s secretions and excretions. In Siliguri, India in 2001, transmission of the virus was also reported within a health-care setting, where 75% of cases occurred among hospital staff or visitors. From 2001 to 2008, around half of reported cases in Bangladesh were due to human-to-human transmission through providing care to infected patients.
SIGNS AND SYMPTOMS
Human infections range from asymptomatic infection to acute respiratory infection (mild, severe), and fatal encephalitis.
Infected people initially develop symptoms including fever, headaches, myalgia (muscle pain), vomiting and sore throat. This can be followed by dizziness, drowsiness, altered consciousness, and neurological signs that indicate acute encephalitis. Some people can also experience atypical pneumonia and severe respiratory problems, including acute respiratory distress. Encephalitis and seizures occur in severe cases, progressing to coma within 24 to 48 hours.
The incubation period (interval from infection to the onset of symptoms) is believed to range from 4 to 14 days. However, an incubation period as long as 45 days has been reported.
Most people who survive acute encephalitis make a full recovery, but long term neurologic conditions have been reported in survivors. Approximately 20% of patients are left with residual neurological consequences such as seizure disorder and personality changes. A small number of people who recover subsequently relapse or develop delayed onset encephalitis.
The case fatality rate is estimated at 40% to 75%. This rate can vary by outbreak depending on local capabilities for epidemiological surveillance and clinical management.
Initial signs and symptoms of Nipah virus infection are nonspecific, and the diagnosis is often not suspected at the time of presentation. This can hinder accurate diagnosis and creates challenges in outbreak detection, effective and timely infection control measures, and outbreak response activities.
In addition, the quality, quantity, type, timing of clinical sample collection and the time needed to transfer samples to the laboratory can affect the accuracy of laboratory results.
Nipah virus infection can be diagnosed with clinical history during the acute and convalescent phase of the disease. The main tests used are real time polymerase chain reaction (RT-PCR) from bodily fluids and antibody detection via enzyme-linked immunosorbent assay (ELISA).
Other tests used include polymerase chain reaction (PCR) assay, and virus isolation by cell culture.
There are currently no drugs or vaccines specific for Nipah virus infection although WHO has identified Nipah as a priority disease for the WHO Research and Development Blueprint. Intensive supportive care is recommended to treat severe respiratory and neurologic complications.
NATURAL HOST: FRUIT BATS
Fruit bats of the family Pteropodidae – particularly species belonging to the Pteropus genus – are the natural hosts for Nipah virus. There is no apparent disease in fruit bats.
It is assumed that the geographic distribution of Henipaviruses overlaps with that of Pteropus category. This hypothesis was reinforced with the evidence of Henipavirus infection in Pteropus bats from Australia, Bangladesh, Cambodia, China, India, Indonesia, Madagascar, Malaysia, Papua New Guinea, Thailand and Timor-Leste.
African fruit bats of the genus Eidolon, family Pteropodidae, were found positive for antibodies against Nipah and Hendra viruses, indicating that these viruses might be present within the geographic distribution of Pteropodidae bats in Africa.
NIPAH VIRUS IN DOMESTIC ANIMALS
Outbreaks of the Nipah virus in pigs and other domestic animals such as horses, goats, sheep, cats and dogs were first reported during the initial Malaysian outbreak in 1999.
The virus is highly contagious in pigs. Pigs are infectious during the incubation period, which lasts from 4 to 14 days.
An infected pig can exhibit no symptoms, but some develop acute feverish illness, labored breathing, and neurological symptoms such as trembling, twitching and muscle spasms. Generally, mortality is low except in young piglets. These symptoms are not dramatically different from other respiratory and neurological illnesses of pigs. Nipah virus should be suspected if pigs also have an unusual barking cough or if human cases of encephalitis are present.
For more information of Nipah in animals, see the Food and Agriculture Organization of the United Nations webpage on Nipah and the World Organization for Animal Health (OIE) webpage on Nipah.
Controlling Nipah virus in pigs
Currently, there are no vaccines available against Nipah virus. Based on the experience gained during the outbreak of Nipah involving pig farms in 1999, routine and thorough cleaning and disinfection of pig farms with appropriate detergents may be effective in preventing infection.
If an outbreak is suspected, the animal premises should be quarantined immediately. Culling of infected animals – with close supervision of burial or incineration of carcasses – may be necessary to reduce the risk of transmission to people. Restricting or banning the movement of animals from infected farms to other areas can reduce the spread of the disease.
As Nipah virus outbreaks have involved pigs and/or fruit bats, establishing an animal health/wildlife surveillance system, using a One Health approach, to detect Nipah cases is essential in providing early warning for veterinary and human public health authorities.
Reducing the risk of infection in people
In the absence of a vaccine, the only way to reduce or prevent infection in people is by raising awareness of the risk factors and educating people about the measures they can take to reduce exposure to the Nipah virus.
Public health educational messages should focus on:
- Reducing the risk of bat-to-human transmission.
Efforts to prevent transmission should first focus on decreasing bat access to date palm sap and other fresh food products. Keeping bats away from sap collection sites with protective coverings (such as bamboo sap skirts) may be helpful. Freshly collected date palm juice should be boiled, and fruits should be thoroughly washed and peeled before consumption. Fruits with sign of bat bites should be discarded.
- Reducing the risk of animal-to-human transmission.
Gloves and other protective clothing should be worn while handling sick animals or their tissues, and during slaughtering and culling procedures. As much as possible, people should avoid being in contact with infected pigs. In endemic areas, when establishing new pig farms, considerations should be given to presence of fruit bats in the area and in general, pig feed and pig shed should be protected against bats when feasible.
- Reducing the risk of human-to-human transmission.
Close unprotected physical contact with Nipah virus-infected people should be avoided. Regular hand washing should be carried out after caring for or visiting sick people.
Controlling infection in health-care settings
Health-care workers caring for patients with suspected or confirmed infection, or handling specimens from them, should implement standard infection control precautions at all times
As human-to-human transmission has been reported, in particular in health-care settings, contact and droplet precautions should be used in addition to standard precautions. Airborne precautions may be required in certain circumstances.
Samples taken from people and animals with suspected Nipah virus infection should be handled by trained staff working in suitably equipped laboratories.
WHO is supporting affected and at risk countries with technical guidance on how to manage outbreaks of Nipah virus and on how to prevent their occurrence.
The risk of international transmission via fruits or fruit products (such as raw date palm juice) contaminated with urine or saliva from infected fruit bats can be prevented by washing them thoroughly and peeling them before consumption. Fruit with signs of bat bites should be discarded.
The Nipah virus, which kills at least half of victims, is one of the world’s next pandemic threats, an expert has warned.
Oxford vaccine creator Professor Dame Sarah Gilbert said there is no vaccine against the virus which causes brain swelling.ut should it evolve to spread at a faster rate, as Covid has learned to do, it could be disastrous.
Dame Sarah said: “Something everybody is very much aware of now, is how SARS-CoV-2 has spread through the world.
“It’s mutated, it’s evolved and what we’ve ended up with is the Delta variant which is very highly transmissible.
“If we get a Delta variant [evolved to be more transmissible] of Nipah virus then suddenly we’ve got a highly transmissible virus with a 50 percent fatality rate.”
During an event at the Cheltenham Literature Festival, Dame Sarah said her team was struggling to raise the money needed to develop vaccines against diseases already known about, yet alone those yet to emerge.
Before starting work on the Oxford-AstraZeneca vaccine in January last year, Dame Sarah said she had been working on vaccines for the Nipah virus, Lassa fever, and Mers.
But her work has gone “backward” since the pandemic.
Dame Sarah said: “We learned in the pandemic that we could do things faster, we could do things better, we want to be applying those lessons, but we still need to get the funding in place to do that. “We need stockpiles of vaccines against these pathogens we already know about because how’s it going to look if suddenly there’s a big Nipah outbreak that starts to spread around the world?
“We’ve known about that for years and we started making a vaccine five years ago, but we haven’t done it yet, it’s not finished.”
Nipah is “top of the list” of ten priority diseases that the World Health Organisation (WHO) has identified as potential sources of future epidemics.
The health agency said in 2018 “there is an urgent need for accelerated research and development for the Nipah virus”.
Scientists have previously told The Sun Nipah could “absolutely be the cause of a new pandemic”.
The southern Indian state of Kerala had to stop a potential outbreak of the virus in September.
It came after a 12-year-old boy died of the disease, prompting the isolation of hundreds of close contacts.
Two healthcare workers who nursed the boy were admitted to the hospital.
Initially, the virus may cause a fever, headache, and respiratory symptoms, before escalating to brain swelling and a coma.
The outbreak was the fifth in India since 2001, according to the WHO, with others-centered in South East Asia.
Outbreaks tend to occur when humans catch Zipah from an animal, making it what’s called a zoonotic disease.
Cases have been blamed on contact with sick pigs or by eating fruit that is contaminated with saliva or urine from infected bats.
There is potential that places like Cambodia, Indonesia, Madagascar, the Philippines, and Thailand are at risk because there are known areas where bats live.